Successful Early Discharge and Avoided Hospitalization for Methicillin-Resistant Staphylococcus aureus Infections Treated With Outpatient Parenteral Antimicrobial Therapy Result in Healthcare Cost Savings

Successful Early Discharge and Avoided Hospitalization for Methicillin-Resistant Staphylococcus aureus Infections Treated With Outpatient Parenteral Antimicrobial Therapy Result in Healthcare Cost Savings

Background. Methicillin-resistant Staphylococcus aureus (MRSA) infections cause over $3 billion in annual hospital costs. They were responsible for 48% of hospital-acquired infections in 2014, for which the federal government will penalize hospitals beginning in 2017....